| PERIOD ENDING | 31-Dec-05 | 31-Dec-04 | 31-Dec-03 | | Total Revenue | 2,902,371 | 2,944,297 | 2,904,440 | | Cost of Revenue | 1,350,243 | 1,354,287 | 1,124,424 | | | Gross Profit | 1,552,128 | 1,590,010 | 1,780,016 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,118,559 | 1,067,123 | 1,221,926 | | Non Recurring | 138,417 | 388,243 | 312,082 | | Others | 40,377 | 1,753,461 | 58,089 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 254,775 | (1,618,817) | 187,919 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 197,112 | 15,689 | (762,625) | | Earnings Before Interest And Taxes | 451,887 | (1,603,128) | (574,706) | | Interest Expense | 288,186 | 255,400 | 289,671 | | Income Before Tax | 163,701 | (1,858,527) | (864,377) | | Income Tax Expense | 142,287 | 153,677 | 137,043 | | Minority Interest | 35,088 | (2,572) | 27,821 | | | | Net Income From Continuing Ops | 56,502 | (2,014,776) | (973,599) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 56,502 | (2,014,776) | (973,599) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $56,502 | ($2,014,776) | ($973,599) |
|
0.51% Nasdaq 
Income Statement
